Cargando…

Efficacy of basiliximab induction in poorly matched living donor renal transplantation

Non-depleting antibody induction has the best safety profile in transplant recipients without an increased risk of infection or malignancy. This observational study was performed in intermediate immunologic risk live donor renal transplants to assess basiliximab efficacy in patients on tacrolimus, m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gundlapalli, S., Rathi, M., Kohli, H. S., Jha, V., Sharma, A., Minz, M., Sakhuja, V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841506/ https://www.ncbi.nlm.nih.gov/pubmed/24339516 http://dx.doi.org/10.4103/0971-4065.120332

Ejemplares similares

Outcomes of spousal versus related donor kidney transplants: A comparative study
por: Mittal, T., et al.
Publicado: (2014)

Spectrum of lymphoproliferative disorders following renal transplantation in North India
por: Sakhuja, V., et al.
Publicado: (2013)

Transmission of human immunodeficiency virus infection by renal transplantation
por: Mukhopadhyay, P., et al.
Publicado: (2012)

Constrictive pericarditis in a renal transplant recipient with tuberculosis
por: Sreejith, P., et al.
Publicado: (2010)

Allograft and prostatic involvement in a renal transplant recipient with disseminated tuberculosis
por: Sreejith, P., et al.
Publicado: (2010)

The role of basiliximab in the evolving renal transplantation immunosuppression protocol
por: Salis, Paola, et al.
Publicado: (2008)

Ulcerative colitis after renal transplantation: A case report and review of literature
por: Parameswaran, S., et al.
Publicado: (2011)

Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry
por: Lee, Jun Young, et al.
Publicado: (2022)

Basiliximab Induction with Delayed Calcineurin Inhibitors for High-Risk Lung Transplant Candidates
por: Kim, Ha Eun, et al.
Publicado: (2021)

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
por: Furukawa, Masashi, et al.
Publicado: (2022)

Outcomes of thymoglobulin versus basiliximab induction therapies in living donor kidney transplant recipients with mild to moderate immunological risk – a retrospective analysis of UNOS database
por: Ali, Hatem, et al.
Publicado: (2023)

An unusual cause of gross hematuria and renal dysfunction in a young male
por: Rathi, M., et al.
Publicado: (2013)

A rare case of cytomegalovirus, scedosporium apiospermum and mycobacterium tuberculosis in a renal transplant recipient
por: Rathi, Manish, et al.
Publicado: (2014)

Thymoglobulin Versus Alemtuzumab Versus Basiliximab Kidney Transplantation From Donors After Circulatory Death
por: Asderakis, Argiris, et al.
Publicado: (2022)

Outcome Comparison between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation
por: Kim, Sang Jin, et al.
Publicado: (2020)

Serum Neopterin Levels Among Hepatitis C-Positive Living-Donor Renal Transplant Recipients
por: Justa, Shivali, et al.
Publicado: (2015)

Basiliximab induction therapy in kidney transplantation: Benefits for long term allograft function after 10 years?
por: Koch, Martina, et al.
Publicado: (2009)

Comparison of Basiliximab and Anti‐Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis
por: Ansari, David, et al.
Publicado: (2015)

The comparative efficacy and safety of basiliximab and antithymocyte globulin in deceased donor kidney transplantation: a multicenter cohort study
por: Hong, Su Yeon, et al.
Publicado: (2023)

Successful induction of granulomatosis with polyangiitis with tacrolimus
por: Ramachandran, R., et al.
Publicado: (2015)

Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation
por: Sageshima, Junichiro, et al.
Publicado: (2009)

Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
por: Lam, Ngan N., et al.
Publicado: (2021)

A Single-center Experience of Kidney Transplantation from Donation after Circulatory Death: Challenges and Scope in India
por: Singh, S., et al.
Publicado: (2017)

Reduced Progression of Cardiac Allograft Vasculopathy with Routine Use of Induction Therapy with Basiliximab
por: Wang, Ricardo, et al.
Publicado: (2015)

Role of basiliximab in the prevention of acute cellular rejection in adult to adult living-related liver transplantation: a single center experience
por: Gruttadauria, S, et al.
Publicado: (2007)

Standard induction with basiliximab versus no induction in low immunological risk kidney transplant recipients: study protocol for a randomized controlled trial
por: Ajlan, Aziza, et al.
Publicado: (2021)

Prospective Controlled Protocol for Three Months Steroid Withdrawal with Tacrolimus, Basiliximab, and Mycophenolate Mofetil in Renal Transplant Recipients
por: Oh, Chang-Kwon, et al.
Publicado: (2012)

The Effect of Monthly Anti-CD25(+) Treatment with Basiliximab on the Progression of Chronic Renal Dysfunction after Lung Transplantation
por: Ross, D. J., et al.
Publicado: (2020)

Association between -1486 T>C and +1174 G>A single nucleotide polymorphisms in TLR9 gene and severity of lupus nephritis
por: Ramachandran, R., et al.
Publicado: (2012)

Impact of Induction Immunosuppressants on T Lymphocyte Subsets after Kidney Transplantation: A Prospective Observational Study with Focus on Anti-Thymocyte Globulin and Basiliximab Induction Therapies
por: Kim, Hyung Duk, et al.
Publicado: (2023)

Authors’ reply
por: Sreejith, P., et al.
Publicado: (2010)

Polyarteritis nodosa presenting with spontaneous perirenal hematoma
por: Mukhopadhyay, P., et al.
Publicado: (2012)

Basiliximab for early perioperative transplant-associated thrombotic microangiopathy after lung transplantation: a case report
por: Ijiri, Naohiro, et al.
Publicado: (2022)

Bone mineral density in patients with end-stage renal disease and its evolution after kidney transplantation
por: Govindarajan, S., et al.
Publicado: (2011)

Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin
por: Jeong, Rachel, et al.
Publicado: (2020)

Application of Ex Vivo Normothermic Machine Perfusion in Deceased Donors With Acute Kidney Injury With Successful Renal Transplantation: A Preliminary Experience
por: Choudhary, Devprakash, et al.
Publicado: (2022)

Early corticosteroid withdrawal regimen in a living donor kidney transplantation program
por: Bansal, S. B., et al.
Publicado: (2014)

The Effect of Stem Cell Transplantation on Immunosuppression in Living Donor Renal Transplantation: A Clinical Trial
por: Trivedi, H. L., et al.
Publicado: (2013)

Lymphocytes as an Indicator for Initial Kidney Function: A Single Center Analysis of Outcome after Alemtuzumab or Basiliximab Induction
por: Weissenbacher, Annemarie, et al.
Publicado: (2015)

Renal Transplantation from Elderly Living Donors
por: Akoh, Jacob A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_19lfhf6494aj6s78phk5pq6ltj